Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy

被引:1
|
作者
Butner, Joseph D. [1 ]
Farhat, Maguy [2 ]
Cristini, Vittorio [1 ,3 ,4 ,5 ]
Chung, Caroline [2 ]
Wang, Zhihui [1 ,3 ,6 ,7 ]
机构
[1] Houston Methodist Res Inst, Math Med Program, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Houston Methodist Res Inst, Neal Canc Ctr, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77230 USA
[5] Weill Cornell Med, Grad Sch Med Sci, Physiol Biophys & Syst Biol Program, New York, NY 10065 USA
[6] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA
[7] Texas A&M Univ, Dept Med Educ, Sch Med, Bryan, TX 77807 USA
来源
STAR PROTOCOLS | 2022年 / 3卷 / 04期
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
Biotechnology and bioengineering; Cancer; Health Sciences; Immunology; Systems biology;
D O I
10.1016/j.xpro.2022.101886
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This protocol describes the application of a mechanistic mathematical model of immune checkpoint inhibitor (ICI) immunotherapy to patient tumor imaging data for predicting solid tumor response and patient survival under ICI intervention. We describe steps for data collection and processing, data pipelines, and approaches to increase precision. The protocol is highly predictive as early as the first restaging after treatment start and can be used with standard-of-care imaging measures. For complete details on the use and execution of this protocol, please refer to Butner et al. (2020)1 and Butner et al. (2021).2
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
    Hung, Hao-Chien
    Lee, Jin-Chiao
    Wang, Yu-Chao
    Cheng, Chih-Hsien
    Wu, Tsung-Han
    Lee, Chen-Fang
    Wu, Ting-Jung
    Chou, Hong-Shiue
    Chan, Kun-Ming
    Lee, Wei-Chen
    CANCERS, 2021, 13 (07)
  • [2] Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
    Krebs, Franziska K.
    Trzeciak, Emily R.
    Zimmer, Sophia
    Oezistanbullu, Deniz
    Mitzel-Rink, Heidrun
    Meissner, Markus
    Grabbe, Stephan
    Loquai, Carmen
    Tuettenberg, Andrea
    CANCER MEDICINE, 2021, 10 (05): : 1562 - 1575
  • [3] Predicting immune checkpoint inhibitor response with mathematical modeling
    Butner, Joseph D.
    Wang, Zhihui
    IMMUNOTHERAPY, 2021, 13 (14) : 1151 - 1156
  • [4] Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy
    Suresh, Karthik
    Psoter, Kevin J.
    Voong, Khinh Ranh
    Shankar, Bairavi
    Forde, Patrick M.
    Ettinger, David S.
    Marrone, Kristen A.
    Kelly, Ronan J.
    Hann, Christine L.
    Levy, Benjamin
    Feliciano, Josephine L.
    Brahmer, Julie R.
    Feller-Kopman, David
    Lerner, Andrew D.
    Lee, Hans
    Yarmus, Lonny
    Hales, Russell K.
    D'Alessio, Franco
    Danoff, Sonye K.
    Naidoo, Jarushka
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 494 - 502
  • [5] Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy
    Butner, Joseph D.
    Dogra, Prashant
    Chung, Caroline
    Koay, Eugene J.
    Welsh, James W.
    Hong, David S.
    Cristini, Vittorio
    Wang, Zhihui
    NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2024, 10 (01)
  • [6] Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma
    Vos, Joris L.
    Traets, Joleen J. H.
    Qiao, Xiaohang
    Seignette, Iris M.
    Peters, Dennis
    Wouters, Michel W. J. M.
    Hooijberg, Erik
    Broeks, Annegien
    van der Wal, Jacqueline E.
    Karakullukcu, M. Baris
    Klop, W. Martin C.
    Navran, Arash
    van Beurden, Marc
    Brouwer, Oscar R.
    Morris, Luc G. T.
    van Poelgeest, Mariette I. E.
    Kapiteijn, Ellen
    Haanen, John B. A. G.
    Blank, Christian U.
    Zuur, Charlotte L.
    JCI INSIGHT, 2024, 9 (21)
  • [7] Prediction of response to Immune Checkpoint Inhibitor Therapy by FDG PET
    Massri, K.
    Dellavedova, L.
    Stoico, R.
    Calcagno, A.
    Maffioli, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S443 - S443
  • [8] Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
    Butner, Joseph D.
    Elganainy, Dalia
    Wang, Charles X.
    Wang, Zhihui
    Chen, Shu-Hsia
    Esnaola, Nestor F.
    Pasqualini, Renata
    Arap, Wadih
    Hong, David S.
    Welsh, James
    Koay, Eugene J.
    Cristini, Vittorio
    SCIENCE ADVANCES, 2020, 6 (18):
  • [9] Ceramide mimetics regulation of tumor cell response to immune checkpoint inhibitor immunotherapy
    Redd, Priscilla S.
    Lu, Chunwan
    Klement, John D.
    Ibrahim, Mohammed
    Yang, Dafeng
    Payne, Daniela
    Lebedyeva, Iryna
    Liu, Kebin
    CANCER RESEARCH, 2019, 79 (13)
  • [10] Gut microbes modulate host response to immune checkpoint inhibitor cancer immunotherapy
    Liu, Kebin
    Lu, Chunwan
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S608 - S610